S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
MarketBeat Week in Review – 9/18 - 9/22
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
WARNING: Seven millionaires to trigger sudden market panic? (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
NASDAQ:INFI

Infinity Pharmaceuticals (INFI) Earnings Date, Estimates & Call Transcripts

$0.02
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.02
$0.03
50-Day Range
$0.02
$0.22
52-Week Range
$0.02
$1.30
Volume
613,225 shs
Average Volume
2.83 million shs
Market Capitalization
$1.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50

Earnings Summary

Upcoming
Earnings Date
Nov. 13Estimated
Actual EPS
(Aug. 10)
-$0.11 Missed By -$0.11
Skip Charts & View Estimated and Actual Earnings Data

INFI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INFI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Infinity Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20232($0.19)($0.12)($0.16)
Q2 20232($0.20)($0.11)($0.16)
Q3 20232($0.21)($0.10)($0.16)
Q4 20232($0.22)($0.10)($0.16)
FY 20238($0.82)($0.43)($0.63)

INFI Earnings Date and Information

Infinity Pharmaceuticals last posted its quarterly earnings data on August 10th, 2023. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter. The company earned $0.58 million during the quarter. Infinity Pharmaceuticals has generated ($0.46) earnings per share over the last year (($0.46) diluted earnings per share). Infinity Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off prior year's report dates.

Infinity Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023
Estimated)
------- 
8/10/2023Q2 2023-($0.11)($0.11)($0.11)-$0.58 million
5/9/2023Q1 2023($0.11)($0.12)($0.01)($0.12)$0.60 million$0.73 million
3/28/2023Q4 2022($0.12)($0.11)+$0.01($0.11)$11.88 million$0.54 million
11/14/2022Q3 2022($0.05)($0.12)($0.07)($0.12)$8.12 million$0.71 million
8/9/2022Q2 2022($0.14)($0.13)+$0.01($0.13)$0.68 million$0.69 million
5/3/2022Q1 2022($0.14)($0.14)-($0.14)$0.40 million$0.65 million    
3/29/2022Q4 2021($0.14)($0.13)+$0.01($0.13)$0.41 million$0.45 million    
11/2/2021Q3 2021($0.14)($0.12)+$0.02($0.12)$0.45 million$0.43 million    
7/27/2021Q2 2021($0.14)($0.13)+$0.01($0.13)$0.39 million$0.51 million
5/13/2021Q1 2021($0.14)($0.15)($0.01)($0.15)$0.46 million$0.47 million  
3/15/2021Q4 2020($0.16)($0.16)-($0.17)$0.39 million$0.44 million  
11/9/2020Q3 2020($0.15)($0.16)($0.01)($0.16)$0.22 million$0.50 million  












Infinity Pharmaceuticals Earnings - Frequently Asked Questions

When is Infinity Pharmaceuticals's earnings date?

Infinity Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off last year's report dates. Learn more on INFI's earnings history.

How much revenue does Infinity Pharmaceuticals generate each year?

Infinity Pharmaceuticals (NASDAQ:INFI) has a recorded annual revenue of $2.59 million.

How much profit does Infinity Pharmaceuticals generate each year?

Infinity Pharmaceuticals (NASDAQ:INFI) has a recorded net income of -$44.37 million. INFI has generated -$0.46 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:INFI) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -